Advancements in AI-driven diagnostics could transform cardiology, enabling autonomous interpretation of up to 80% of cardiac imaging within a decade. David Ouyang, MD, discusses overcoming barriers to running…
NEW YORK (Reuters Health) – Stent fractures are not always associated with clinical sequelae, but they do increase the likelihood of in-stent restenosis (ISR) and target lesion revascularization…
NEW YORK (Reuters Health) – Implantable cardioverter-defibrillators (ICDs) used to prevent sudden cardiac death in patients with severe left ventricular dysfunction significantly improve survival in younger patients, but…
NEW YORK (Reuters Health) – Rosuvastatin halves the rate of primary cardiovascular events in patients who have a high global cardiovascular risk profile, according to a post hoc…
Francis G. Spinale, MD, PhD, Medical University of South Carolina, discusses controlling BP using biomarkers to tell us if we should add on antihypertensive therapy. Related Reading Angiotensin-(1-7)…
NEW YORK (Reuters Health) – In patients with mixed dyslipidemia, fenofibric acid added to atorvastatin and ezetimibe results in improved lipid and non-lipid levels, according to a report…
Sandeep Jauhar, MD, cardiologist and author, describes, via his office webcam, the experience of being an intern and the subject of his book, Intern: A Doctor’s Initiation, a…
NEW YORK (Reuters Health) – For patients with rheumatoid arthritis (RA), treatment with anti-tumor necrosis factor (TNF) agents appears to reduce their risk of cardiovascular events, including MI…
NEW YORK (Reuters Health) – Postmenopausal women treated for osteoporosis with the selective estrogen receptor modulator lasofoxifene have a reduced risk of coronary heart disease events, researchers report…
NEW YORK (Reuters Health) – Among low-risk patients undergoing elective percutaneous coronary intervention, 1-year outcomes are worse if their antiplatelet response to clopidogrel is low, an Italian team…
NEW YORK (Reuters Health) – In patients being treated for acute coronary syndromes (ACS), the loading dose of ticagrelor has a stronger inhibitory effect on platelets than does…
